Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Genomics Sequencing Core Facility
Providing integrative medicine to underserved patients through group medical visits
Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans
Development and Regeneration in Trigeminal System
Grants for Faculty Development in Family Medicine
Recently added grants:
Rational design and B cell responses of HIV epitope vaccines
Viral and Host Determinants of Chikungunya Virus Dissemination
CELL TYPE-SPECIFIC CONTROL of GENE EXPRESSION by RIBOSOMAL PROTEIN ISOFORMS
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth
MSC-Derived Exosomes and MicroRNA in Glioma Therapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07158-17-0-1
Application #
7574920
Study Section
Project Start
2000-09-01
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
$498,315
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Iyer, Rathi V. /
$406,252
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant